Fertil Steril (2006) 85:140914
Machado MC, Fonseca GM, Jukemura J
SUBCELLULAR LOCALIZATION ANALYSIS For the construction of the fusion gene constructs of 35S pro :As GGT1 N100 :GFP , 35S pro :AsGGT2 N100 :GFP , and 35S pro :AsGGT3 N100 :GFP , partial coding regions of AsGGT1 , AsGGT2 , and AsGGT3 that encode the N-terminal 100 amino acid residues were amplified by PCR using KOD plus DNA polymerase (Toyobo) and the following gene-specific primers: AsGGT1-FSal (5- GTCGAC ATGAACCAAATGGCGCCGGCTTCTTC-3) and AsGGT1-N100-RNco (5- CCATGG AACCACCACCACCACC ACCTTTTCTCAGAACTGAAGCTCC-3) for AsGGT1
Areas Without Adequate Human Evidence Cardiovascular safety Neurological and psychiatric effects Liver and kidney safety Effects on blood glucose in humans Effects on methylation pathways Genotoxicity Carcinogenicity Reproductive and developmental toxicity Use during pregnancy or breastfeeding Interactions with prescription medicines Interactions with supplements or research compounds Long-term exposure Product-Quality Risks Incorrect quinolinium compound Wrong substitution position Incorrect counterion Incorrect active-content calculation Residual starting materials Residual solvents Degradation products Heavy-metal or inorganic contamination Mismatched certificate of analysis Uncontrolled storage and transport Absence of published harm is not proof of safety A compound without routine regulated human exposure may generate very few formal safety reports simply because there is no organised pharmacovigilance system
Since synthetic vitamins were first used in the late 1930s, humankind has undergone the most massive increase in vitamin use in history
Importantly, the presence of side effects may also serve as a clinical cue that the appetite-regulating mechanism is active , though any severe or persistent symptoms warrant reevaluation of dose or co-therapy timing
